Evonik more robust as strategy takes effect

Promised and delivered: adjusted EBITDA climbs to €2.6 billion

06-Mar-2019 - Evonik grew again strongly in 2018. Adjusted EBITDA increased 10 percent to €2.6 billion, compared with the previous year. All three chemical segments contributed to profit growth. The earnings forecast, that Evonik had raised after the first half of the year, was achieved despite external ...

Evonik agrees to sell its Methacrylates business

Consistent strategy execution to focus on specialty chemicals

05-Mar-2019 - Evonik has signed an agreement to sell its Methacrylates business to Advent International for €3 billion. The selling price (enterprise value) is 8.5 times the business’ EBITDA. The transaction is subject to approval by the authorities in several countries and is expected to close in the third ...

Evonik invests in start-ups

Evonik More Than Doubles Venture Capital to Accelerate Innovation

14-Feb-2019 - Evonik has launched its second venture capital fund with a volume of €150 million, more than doubling the amount under management to €250 million. The new fund will help secure access to disruptive technologies and innovative business models as well as supporting Evonik’s digital transformation ...

Evonik acquires US-based startup Structured Polymers

18-Jan-2019 - Evonik has acquired Structured Polymers Inc., a US-based technology startup for 3D printing materials headquartered in Austin, Texas. A corresponding agreement and plan of merger was executed and the transaction has been closed recently. The acquisition will provide Evonik access to a new ...

Evonik appoints new managers to its segments’ boards

03-Dec-2018 - Johann-Caspar Gammelin, currently Chairman of the Board of Management of Evonik Performance Materials GmbH, will take over as Chairman of the Board of Management of Evonik Nutrition and Care GmbH from Dr. Reiner Beste, effective April 1, 2019. On this date Dr. Beste, as new Regional President, ...

Evonik concludes sale of its Jayhawk site

Company continues to focus on high-margin specialty chemicals businesses

05-Nov-2018 - Evonik has concluded the sale of its Jayhawk site in Galena (Kansas, USA), taking the next step on the road to a consistent focus on specialty chemicals. Funds advised by Permira, an international investment company, acquired the site at a price in the high double-digit million dollar range. The ...

Evonik starts production of precipitated silica in South Carolina

Investment of about US$120 million creates more than 40 new jobs

18-Oct-2018 - Evonik Industries has started up a precipitated silica plant for the tire industry in South Carolina, in southeastern USA. Evonik has invested about US$120 million in this world-scale production plant, in response to the high demand from the tire industry for precipitated silica in North America. ...

Evonik sells its US Jayhawk site

Company continues to intensify focus on high-margin specialty chemicals businesses

03-Sep-2018 - Evonik is taking the next step in systematically focusing on specialty chemicals with the divestment of its US Jayhawk site in Galena, Kansas. The site produces precursors for agrochemicals, which are not included in the growth businesses defined by Evonik. “We want to continue growing profitably ...

Evonik and Chinese company Wynca agree to form joint venture to produce fumed silica

Investment amount in the mid double-digit million Euro range

22-Aug-2018 - Evonik Industries and the Chinese company Wynca have agreed to form a joint venture. The new company, in which Evonik will hold 60 percent, will produce fumed silica marketed under the name AEROSIL®. The product is used in transparent silicones, coatings and paints, modern adhesives as well as ...

Evonik: Strong results for the second quarter

03-Aug-2018 - Evonik increased adjusted EBITDA to €742 million in the second quarter of 2018 (prior-year: €640 million). All three chemical segments contributed with excellent operational business development: All three segments were able to increase their adjusted EBITDA as well as EBITDA margin compared to ...